MENU

CNTX Context Therapeutics Forecast, Technical & Fundamental Analysis

Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors... Show more

CNTX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
View a ticker or compare two or three
CNTX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

CNTX is expected to report earnings to rise 1.44% to -9 cents per share on August 12

Context Therapeutics CNTX Stock Earnings Reports
Q2'26
Est.
$-0.09
Q1'26
Beat
by $0.02
Q4'25
Missed
by $0.04
Q3'25
Missed
by $0.01
Q2'25
Missed
by $0.03
The last earnings report on May 06 showed earnings per share of -9 cents, beating the estimate of -11 cents. With 14.42M shares outstanding, the current market capitalization sits at 60.06M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Details
Industry
N/A
Address
2001 Market Street
Phone
+1 267 225-7416
Employees
15
Web
https://www.contexttherapeutics.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
OTCNX79.39N/A
N/A
Invesco Discovery Large Cap R
GGGCX48.58N/A
N/A
Gabelli Global Growth C
TVLRX12.64N/A
N/A
Touchstone Value R6
RCEAX12.24N/A
N/A
RBC China Equity A
PGINX24.62-0.23
-0.93%
Impax Global Environmental Markets Instl

CNTX and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, CNTX has been loosely correlated with ELTX. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if CNTX jumps, then ELTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CNTX
1D Price
Change %
CNTX100%
N/A
ELTX - CNTX
50%
Loosely correlated
N/A
NMRA - CNTX
41%
Loosely correlated
N/A
TRAW - CNTX
32%
Poorly correlated
N/A
PROK - CNTX
29%
Poorly correlated
N/A
MREO - CNTX
27%
Poorly correlated
N/A
More
Context Therapeutics (CNTX) stock Forecast, Price Targets and Analysts Predictions - Tickeron.com